CAT and type 2 diabetes mellitus: LJF ameliorated the symptoms of T2DM in a dose-dependent manner, involving reduction in weight loss, cholesterol, FBG, triglyceride, and free fatty acids, and increases in glucagon-like peptide-1, high-density lipoprotein cholesterol, superoxide dismutase, and catalase.